Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Credit Rating

Novartis India Credit Rating

Evonile Pharma Limited has received credit ratings from CARE Ratings Limited for its bank facilities. The company disclosed the ratings as part of its regulatory filings.

Source

BSE filing, NSE: NOVARTIND. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Novartis India Ltd: key numbers

Share price
₹1,805.95
Market cap
₹4,459 Cr
Revenue (annual)
₹354.3 Cr
Net profit (annual)
₹93.18 Cr
P/E (TTM)
45.6×Sector 46.1×
Promoter holding
70.68%+0.00% QoQ
FII holding
1.21%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Novartis India Ltd

All →
19:01 IST BSE
Fund Raise

Novartis India Fund Raise of ₹900 Cr

Evonile Pharma Limited approved a rights issue to raise up to ₹900 Crore. The company also formed a committee to manage the issuance terms.

Value
₹900.0 Cr

Other credit rating announcements

All →